Medicare Enrolled

Dr. David Kamelhar, MD

Pulmonary Disease · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
404 PARK AVE S, New York, NY 10016
2126856611
In practice since 2005 (20 years)
NPI: 1891795787 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kamelhar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kamelhar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kamelhar

Dr. David Kamelhar is a pulmonary disease specialist in New York, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kamelhar performed 6,023 Medicare services across 3,640 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kamelhar received a total of $88,670 from 22 pharmaceutical and/or device companies across 385 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kamelhar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 4% volume in NY $88,670 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,023
Medicare services
Top 4% in NY for pulmonary disease
3,640
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~301 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,297 $108 $205
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
1,175 $51 $248
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
1,111 $36 $249
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
917 $68 $175
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
671 $53 $248
New patient office visit, complex (60-74 min) 218 $198 $499
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
162 $156 $345
Exercise-induced lung stress test
A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising.
101 $31 $500
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
79 $8 $50
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
74 $25 $175
Remote patient monitoring management, 20 min/month
Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month.
53 $45 $75
Remote vital sign monitoring management, each additional 20 minutes
This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period.
49 $36 $52
Remote patient monitoring device, 30 days
Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period.
30 $48 $100
Breathing device use evaluation
An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling.
29 $17 $100
Nitric oxide gas level test
A test that measures the level of nitric oxide gas in the body.
24 $18 $100
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
11 $154 $325
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
11 $165 $300
Remote physiologic monitoring setup and education
Initial setup of remote monitoring equipment and patient education on its use.
11 $19 $50
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$88,670
Total received (2018-2024)
Avg $12,667/year across 7 years
Top 5% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
385
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$43,033 (48.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$42,008 (47.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,628 (4.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,456
2023
$24,357
2022
$14,327
2021
$9,277
2020
$5,063
2019
$33,432
2018
$759

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Insmed, Inc.
$673
AstraZeneca Pharmaceuticals LP
$320
GlaxoSmithKline, LLC.
$171
Baxter Healthcare
$75
Boehringer Ingelheim Pharmaceuticals, Inc.
$70
Amgen Inc.
$50
Philips North America LLC
$49
Regeneron Healthcare Solutions, Inc.
$27
Mylan Specialty L.P.
$22
Top 3 companies account for 79.9% of 2024 payments
All-time payments by company (2018-2024) ›
Insmed, Inc.
$85,674
Sunovion Pharmaceuticals Inc.
$992
AstraZeneca Pharmaceuticals LP
$502
GlaxoSmithKline, LLC.
$437
Philips Electronics North America Corporation
$329
Medtronic, Inc.
$103
Ethicon US, LLC
$103
Baxter Healthcare
$75
Boehringer Ingelheim Pharmaceuticals, Inc.
$70
Amgen Inc.
$50
Philips North America LLC
$49
Merck Sharp & Dohme Corporation
$45
Regeneron Healthcare Solutions, Inc.
$42
Pulmonx Corporation
$34
Jazz Pharmaceuticals Inc.
$33
Itamar Medical Inc
$28
Mylan Specialty L.P.
$22
Advanced Respiratory, Inc
$21
Mallinckrodt Hospital Products Inc.
$16
IDORSIA PHARMACEUTICALS US INC
$15
Teva Pharmaceuticals USA, Inc.
$15
Genentech USA, Inc.
$13
Top 3 companies account for 98.3% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · AREXVY · ARIKAYCE · Arikayce · BREZTRI · CHARTIS CATHETER · CINQAIR · DUPIXENT · ENDOFLIP · Esbriet · FASENRA · Hillrom - Vest System Model 105 Home Care · LINX Reflux Management System · LONHALA MAGNAIR · NUCALA · OFEV · QUVIVIQ · Respiratoriy Care Undiv · TEZSPIRE · TRELEGY ELLIPTA · The MetaNeb System · Trilogy 100 · UTIBRON NEOHALER · Utibron · WatchPAT · Wellcentive Undiv · XYWAV · YUPELRI · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (48%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for pulmonary disease in NY.

Looking for a pulmonary disease specialist in New York?
Compare pulmonary diseases in the New York area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
651
Per 100K population
40.0
County median income
$104,553
Nearest hospital
BELLEVUE HOSPITAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kamelhar is a clinical cardiology specialist, with above-average Medicare volume (top 4% in NY), with consulting-driven industry engagement in the top 5% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kamelhar experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kamelhar performed 1,297 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kamelhar receive payments from pharmaceutical companies?
Yes. Dr. Kamelhar received a total of $88,670 from 22 companies across 385 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kamelhar's costs compare to other pulmonary diseases in New York?
Dr. Kamelhar's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kamelhar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →